By Anthony Oliva, PhD
Updated August 28, 2026
If you’ve started researching newborn stem cell banking, you have probably run into two different offers that sound similar on the surface: cord blood banking and stem cell banking. They collect different cells, for different purposes, and process differently at different costs. That distinction is what the rest of this comparison is actually about. (Just want the basics? Our beginner’s guide to stem cell banking is a good place to start first.)
Cord blood banking vs. stem cell banking: what’s actually different
Both involve stem cells, but they preserve different cell types and quantities. Cord blood banking primarily preserves a limited amount of Hematopoietic Stem Cells (HSCs), while the newborn stem cell banking discussed here focuses on Mesenchymal Stem Cells (MSCs).
Cord blood banking (HSCs)
Cord blood banking collects blood left in the umbilical cord after birth. It contains a very small amount of hematopoietic stem cells (HSCs), which are used in bone marrow transplants for blood and immune conditions, and some Mesenchymal Stem Cells (MSCs). In private banking, HSCs are typically frozen as collected, leaving a small fixed amount of HSCs.
Cord blood banks do not routinely expand HSCs, so the quantity collected at birth is the quantity available later. Public cord blood banks primarily support unrelated donor transplants, although some accept directed donations for siblings with diagnosed conditions (ACOG, 2019, and the American Academy of Pediatrics).
VitalCells does not perform donor matching. Its banking model is designed around preserving cells for the child’s own potential future use, also known as autologous.
Stem cell banking (MSCs)
Newborn stem cell banking collects mesenchymal stem cells (MSCs), found mainly in cord tissue and, in smaller amounts, cord blood. Unlike HSCs, MSCs can proliferate extensively in standard culture and self-replicate. In fact, their ability to adhere to plastic and proliferate in culture is part of how MSCs are characterized (Dominici et al., 2006).
That expandability is what allows a small starting sample to become a much larger, documented supply, preserved for the child’s own future use. MSCs are the subject of active research across many areas of medicine (Caplan & Correa, 2011), and that research is not a statement about what a banked sample can do for any individual.
What drives the cost difference
Processing
Cord blood processing isolates and freezes HSCs without routine expansion, so the fee primarily reflects collection, processing, and storage. Cord blood processing is typically done under an hour through an automated processing system. Stem cell banking with expansion adds another step: isolating and growing MSCs into a larger, documented cell supply over a 10-to-12-week process. That step matters because typical MSC dosing in clinical research can require substantial cell quantities (Zeng et al., 2022). Expanding the cells before banking adds processing complexity and cost, but also changes the quantity available for future use.
Storage duration
Both models offer annual or prepaid long-term plans, and the numbers behind them differ more than the labels suggest. As of August 2026, industry-wide annual storage runs about $370 to $420 a year for cord blood and cord tissue together, and the VitalCells rate is $350, and prepaid multi-year plans (10, 18, or 25 years) lock in a discounted rate up front, roughly $2,975, $5,040, or $6,563 depending on the term. See the full storage fee and discount breakdown. Put another way, the stem cell preservation cost primarily reflects what it takes to maintain a cryopreserved sample, rather than the number of cells it contains. An unexpanded sample can therefore cost nearly as much to store each year as a documented, expanded one.
Growing a specific cell quantity
This is a step that is not included in every cord blood or cord tissue banking model: turning a small starting sample into a documented quantity of live cells. Where it’s available, it may be priced separately from the base processing fee, either on demand or as a prepaid package.
What each option costs, side by side
| Cord blood banking (HSCs only) |
Cord tissue, storage-only |
VitalCells (expanded MSCs) |
|
|---|---|---|---|
| Cell type collected | HSCs, limited | Cord tissue frozen whole, MSCs not isolated or counted | Expanded MSCs via CellMaxx, with a documented live-cell count |
| Initial processing | $1,500–$2,500 | Add-on fee, varies by provider | $4,500, one time |
| Routine expansion included | No | No | Yes |
| Growth guarantee | Ask provider | Ask provider | Refund guarantee if growth fails |
| Banking approach | Established HSC transplant applications | Tissue preserved as collected, without an expansion step | Your child’s own future use |
Cord blood and unexpanded cord tissue banking typically total about $1,400 to $2,900 upfront, plus roughly $370 to $420 a year. These costs generally cover collection, processing, and storage rather than expansion to a defined cell quantity.
What VitalCells includes at its base price
VitalCells’ $4,500 processing fee covers collection, processing, and initial CellMaxx expansion, backed by a refund guarantee if the cells do not grow successfully. Growing a specific, larger quantity of cells for active use is priced separately, either on demand or as a prepaid package.
MSCs are the subject of active research across many areas of medicine (Caplan & Correa, 2011). That research is ongoing, it does not establish that banking or any procedure using these cells treats or cures a specific condition, and any procedure is always performed by a licensed physician, not by VitalCells itself.
Choosing What’s Best For Your Family
Cord blood and unexpanded cord tissue banking are more affordable upfront, but they preserve a fixed starting sample rather than an expanded cell supply. Their established clinical uses are narrower (ACOG, 2019). Cord blood HSCs have been used in hematopoietic stem cell transplantation, while unexpanded cord tissue preserves MSC-containing tissue without growing those cells, and has been used in a limited number of cases.
Stem cell banking through CellMaxx includes an expansion step during processing, with a documented live-cell count at the end of it. The initial expansion is backed by a refund guarantee if the cells do not grow, with the option to grow a larger quantity later.
See the full side-by-side comparison and pricing tiers on our newborn banking plans and pricing page, no call required. Have questions specific to your situation? Contact us.
References
Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy. 2006;8(4):315–317. doi:10.1080/14653240600855905
Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11–15. doi:10.1016/j.stem.2011.06.008
Zeng L, et al. Efficacy and safety of mesenchymal stem cell transplantation in the treatment of autoimmune diseases. Stem Cells Int. 2022;2022:9463314. doi:10.1155/2022/9463314
American College of Obstetricians and Gynecologists. Umbilical cord blood banking. Committee Opinion No. 771. Obstet Gynecol. 2019;133(3):e249–e253.
This blog is for educational purposes only and does not constitute medical advice. It does not make any express or implied claims about the effectiveness, safety, or suitability of any procedure or therapy mentioned. VitalCells does not provide medical treatment. All procedures are performed by licensed, independent physicians. Always consult your own physician before making any health-related decision.